XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $145,277,903 | -27.3% | 4,252,866 | -18.0% | 0.01% | -23.5% |
Q2 2023 | $199,765,220 | -41.0% | 5,188,707 | -45.1% | 0.02% | +13.3% |
Q1 2023 | $338,419,432 | +83.0% | 9,455,698 | +101.6% | 0.02% | -16.7% |
Q4 2022 | $184,959,387 | +9.7% | 4,690,829 | +0.5% | 0.02% | 0.0% |
Q3 2022 | $168,578,000 | +21.2% | 4,669,759 | +2.1% | 0.02% | +28.6% |
Q2 2022 | $139,091,000 | +18.7% | 4,572,368 | +19.3% | 0.01% | +55.6% |
Q1 2022 | $117,190,000 | -4.1% | 3,833,476 | -2.0% | 0.01% | 0.0% |
Q4 2021 | $122,149,000 | +161.5% | 3,910,017 | +27.9% | 0.01% | +125.0% |
Q3 2021 | $46,707,000 | -18.4% | 3,056,756 | -0.5% | 0.00% | 0.0% |
Q2 2021 | $57,209,000 | +3.5% | 3,072,444 | -0.5% | 0.00% | -20.0% |
Q1 2021 | $55,262,000 | +36.9% | 3,087,244 | +17.6% | 0.01% | +25.0% |
Q4 2020 | $40,381,000 | +39.0% | 2,625,552 | +0.0% | 0.00% | +33.3% |
Q3 2020 | $29,055,000 | +5.4% | 2,624,620 | +19.4% | 0.00% | 0.0% |
Q2 2020 | $27,576,000 | +53.2% | 2,199,054 | +38.5% | 0.00% | +50.0% |
Q1 2020 | $18,003,000 | +145.8% | 1,587,536 | +74.3% | 0.00% | +100.0% |
Q4 2015 | $7,324,000 | -2.7% | 910,920 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $7,524,000 | -42.8% | 910,920 | -20.2% | 0.00% | -50.0% |
Q2 2015 | $13,157,000 | -37.9% | 1,141,062 | -9.2% | 0.00% | -33.3% |
Q1 2015 | $21,184,000 | -14.6% | 1,256,239 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $24,811,000 | – | 1,256,239 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |